The significant miss in both earnings per share and sales compared to analyst estimates, coupled with the drastic decrease from the previous year's figures, suggests a negative short-term impact on SGMO's stock price. The magnitude of the miss and the comparison to last year's performance are critical factors indicating potential investor concern over the company's financial health and future prospects.